126th MAINE LEGISLATURE
		LD 951		LR 1577(02)
	An Act To Repeal the 2-year Limit on Methadone and Suboxone Treatments under MaineCare
	Fiscal Note for Bill as Amended by Committee Amendment " "
	Committee: Health and Human Services
	Fiscal Note Required: Yes
Fiscal Note
			FY 2013-14	FY 2014-15	Projections  FY 2015-16	Projections  FY 2016-17
Net Cost (Savings)
	General Fund		$578,339	$1,304,913	$1,903,338	$1,903,338
Appropriations/Allocations
	General Fund		$578,339	$1,304,913	$1,903,338	$1,903,338
	Federal Expenditures Fund		$935,836	$2,088,877	$3,046,825	$3,046,825
Fiscal Detail and Notes
	This bill includes General Fund appropriations totalling $578,339 in fiscal year 2013-14 and $1,304,913 in fiscal year 2014-15 for the Department of Health and Human Services.  It includes a General Fund appropriation of $207,956 in fiscal year 2013-14 and $807,772 in fiscal year 2014-15 to allow MaineCare reimbursement for buprenorphine and naloxone combination drugs and methadone for the treatment of addiction to opioids under certain conditions.  The General Fund cost to increase the MaineCare rate paid to methadone clinics is $370,383 in fiscal year 2013-14 and $497,141 in fiscal year 2014-15.